NCT01566760View on ClinicalTrials.gov

A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

fesoterodine fumarate

One capsule of 4 mg PF-00695838 Formulation SR1 under fasting conditions, single dose

DRUG

fesoterodine fumarate

One capsule of 4 mg PF-00695838 Formulation SR2 under fasting conditions, single dose

DRUG

fesoterodine fumarate

One capsule of 4 mg PF-00695838 Formulation SR1 under fed conditions, single dose

DRUG

fesoterodine fumarate

One capsule of 4 mg PF-00695838 Formulation SR2 under fed conditions, single dose

DRUG

fesoterodine fumarate

one extended-release tablet of commercially available fesoterodine fumarate 4 mg under fasting conditions, single dose

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01566760 - A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers | Biotech Hunter | Biotech Hunter